Press release
Cathepsin S (CTSS or EC 3.4.22.27) Market -Pipeline Review, H2 2017
About Cathepsin S Market
Cathepsin S (CTSS or EC 3.4.22.27) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report Cathepsin S (CTSS or EC 3.4.22.27)-Pipeline Review, H2 2017, outlays comprehensive information on the Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Cathepsin S (CTSS or EC 3.4.22.27)-Cathepsin S is a lysosomal enzyme that belongs to the papain family of cysteine proteases. Cathepsin S has a role in itch and pain, or nociception. The nociceptive activity results from cathepsin S functioning as a signaling molecule via activation of protease-activated receptors 2 and 4 members of the G-protein coupled receptor family. Cathepsin S has a physiological role outside the lysosome. Immune cells, including macrophages and microglia, secrete cathepsin S in response to inflammatory mediators including lipopolysaccharides, proinflammatory cytokines and neutrophils. The molecules developed by companies in Phase II, Phase I, Phase 0, Preclinical and Discovery stages are 1, 1, 1, 6 and 1 respectively. Report covers products from therapy areas Central Nervous System, Immunology, Gastrointestinal, Oncology, Infectious Disease, Metabolic Disorders and Musculoskeletal Disorders which include indications Neuropathic Pain, Rheumatoid Arthritis, Alzheimer's Disease, Autoimmune Disorders, Cancer Pain, Celiac Disease, Chagas Disease (American Trypanosomiasis), Colorectal Cancer, Crohn's Disease (Regional Enteritis), Diabetic Retinopathy, Liver Fibrosis, Lupus Nephritis, Osteoarthritis, Pancreatic Cancer, Primary Biliary Cirrhosis, Sicca Syndrome (Sjogren) and Systemic Lupus Erythematosus.
Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/1339576
Furthermore, this report also reviews key players involved in Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape for Cathepsin S (CTSS or EC 3.4.22.27)
- The report reviews Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics and enlists all their major and minor projects
- The report assesses Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics
View Sample PDF @ https://www.marketresearchreports.biz/reports/1339576/cathepsin-s-ctss-or-ec-342227-pipeline-review-h2-2017-market-research-reports.pdf
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Cathepsin S (CTSS or EC 3.4.22.27)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cathepsin S (CTSS or EC 3.4.22.27) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Cathepsin S (CTSS or EC 3.4.22.27)-Overview 6
Cathepsin S (CTSS or EC 3.4.22.27)-Therapeutics Development 7
Products under Development by Stage of Development 7
Products under Development by Therapy Area 8
Products under Development by Indication 9
Products under Development by Companies 10
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiry/1339576
Cathepsin S (CTSS or EC 3.4.22.27)-Therapeutics Assessment 12
Assessment by Mechanism of Action 12
Assessment by Route of Administration 13
Assessment by Molecule Type 14
Cathepsin S (CTSS or EC 3.4.22.27)-Companies Involved in Therapeutics Development 16
Amura Holdings Ltd 16
F. Hoffmann-La Roche Ltd 16
Fusion Antibodies Ltd 16
Sanofi 17
Virobay Inc 17
Cathepsin S (CTSS or EC 3.4.22.27)-Drug Profiles 19
AM-3840-Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
AM-3876-Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Fsn-0503h-Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
RG-7625-Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
RO-5461111-Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
SAR-114137-Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
VBY-129-Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
VBY-285-Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
VBY-50365-Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
VBY-825-Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cathepsin S (CTSS or EC 3.4.22.27) Market -Pipeline Review, H2 2017 here
News-ID: 761833 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Cathepsin
Cathepsin Inhibitors Market To Witness Substantial Growth, 2025-2032 | Hoffmann- …
The qualitative latest Research report (2025-2032) on the Cathepsin Inhibitors Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/2306
Focused on growth and…
Cathepsin Inhibitors Market Projected To Witness Massive Growth, 2025-2032 | Mer …
The Latest comprehensive Research Report on the Cathepsin Inhibitors Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. The Cathepsin Inhibitors Market report has been designed after a Research Scope and Methodologies of various segments such as share, demand analysis, growth figure,…
Cathepsin Inhibitors Market Size, Growth, Demand, Development, Dynamics, Scope, …
Data Bridge Market Research analyzes that the Cathepsin Inhibitors Market is expected to grow at a CAGR of 4.30% during the forecast period 2021-2028. Cathepsins are the main proteases available in various living organisms responsible for maintaining optimal cell turnover of proteins. mobile phone. There are different variants of cathepsin inhibitors, with each variant claiming different utility and benefits against various diseases, such as Ebola infection, cancer, brain damage,…
Cathepsin Inhibitors Market See Incredible Growth 2022-2028 | Merck Sharp & Dohm …
Coherent Market Insights has released a new research study on the "Cathepsin Inhibitors Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Cathepsin Inhibitors Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Cathepsin Inhibitors Market research report is an intelligence…
Anti-Cathepsin B Industry Landscape and its Growth Prospect By 2020-2030
Anti-Cathepsin B Market: Introduction
Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues.
Report Overview: https://www.transparencymarketresearch.com/anticathepsin-b-market.html
Key Drivers and Restraints of Global Anti-Cathepsin B Market
•Rise in incidence rate of cancer across the globe is a major…
Anti-Cathepsin B Market global outlook and forecast 2021 -2027| Virobay Inc.,Abc …
The Global Anti-Cathepsin B Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Anti-Cathepsin B makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements.
The report likewise spins around…
